We are live on
!
Find out more
UL
Ulys LLC Portfolio holdings
AUM
$25.4M
1-Year Est. Return
201.03%
This Fund
S&P 500
This Quarter
Est. Return
+21.77%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$34.8M
AUM Growth
+$6.35M
(+22%)
Cap. Flow
-$7
Cap. Flow
% of AUM
-0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lexicon Pharmaceuticals
LXRX
|
+$7 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.98% |
Similar funds
WSC
AGEC
OHS
LW
PCG
FC
EFM
NI
Ulys LLC's Q2 2015 Portfolio in Review
As of Q2 2015, Ulys LLC held 2 positions worth $34.8M, up 22% from $28.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.
- Ulys LLC's biggest Q2 2015 reduction was Lexicon Pharmaceuticals, cutting an estimated $7.
- Ulys LLC's ten largest holdings make up 100% of its $34.8M portfolio in Q2 2015.
- Ulys LLC opened 0 new positions and closed 0 in Q2 2015.
- Ulys LLC's portfolio value rose 22% quarter-over-quarter to $34.8M.
Based on Ulys LLC's 13F filing for Q2 2015, filed 13 Aug 2015.